K. G. M. M. Alberti, M. Koike and S. Numa (the last two contributors were nominated by the Japanese Biochemical Society).
Hans Krebs was born in 1900 in Hildesheim, a small town in northern Germany. His father was an ear, nose and throat surgeon and played a major role in his son's decision to take up medicine. A second key factor in shaping the subsequent development of Sir Hans's research interests was his appointment as research assistant in the laboratory of Otto Warburg. This was a golden age of German biochemistry, and the Kaiser Wilhelm Institute, Berlin, was one of the centres of excellence. It was from Warburg that he learnt the simple but elegant techniques of manometry, spectrophotometry and preparation of tissue slices that were to form the basis for much of his future research.
After five fruitful years with Warburg, Sir Hans was appointed Assistant in Medicine in the University of Freiburg. It was here that he and a clinical student, K. Henseleit, demonstrated that liver slices readily synthesized urea from ammonia and sources of carbon and energy, and that ornithine and citrulline acted catalytically in this process. The description of the first metabolic cycle (1932) was rapidly recognized as a major achievement by the international biochemical community. Shortly after publication of this work Sir Hans was dismissed from his post in Freiburg under the anti-Semitic legislation introduced by Hitler. He emigrated to England (1 933) and accepted Sir Frederick Gowland Hopkins's invitation to join the Department of Biochemistry in Cambridge.
In Cambridge, he continued the work on amino acid metabolism that he had commenced in Freiburg. He demonstrated the formation of glutamine from glutamate and ammonia and its hydrolysis in animal tissues. This was followed by studies on the synthesis of uric acid by avian liver and on the formation of ketone bodies (with the late N. L. Edson). These two areas of metabolism continued to occupy his interest over the years.
In We now report experiments that show that these two dysfunctions can be independently suppressed: they are therefore not causally related.
(13 Restoration of preference for glucose without augmentation of adenylate cyclase activity
Strains of E. coli that carry the mgl and gulp markers and thus lack the active-transport systems for galactose can still grow on that hexose. In such strains, galactose is taken up by facilitated diffusion, mediated by the principal Enzyme I1 for glucose transport, enzyme PtsG (Kornberg & Riordan, 1976) . Mutants that are ptsG grow very poorly on agar plates containing galactose as carbon source; if, in addition, they are tgs, no growth is observed over at least 2 days. In strain PW 26, the ptsl gene had additionally been replaced by ptsP; the Enzyme I of the phosphotransferase system in this strain was active at 30°C but inactive at 37OC and above. Mutants of PW 26 were selected for their ability to grow on galactose at 3OOC. Among them were some that did not grow on this hexose at 37°C: they were still ptsP mglgalP but contained an alteration, designated ptsGS, that was co-transducible with ptsG and that restored the sensitivity to 5-thio-~-glucose and the utilization of glucose in preference to sugars taken up via the phosphotransferase system. One such mutant, PW 3 1, was studied further: it was shown still to carry the tgs marker, since that could be transferred by transduction into other strains, and its adenylate cyclase activity was as low as observed with the parent tgs strain.
(ii) A Iterations of adenylate cyclase activity without restoration of the preferential utilization of glucose Two types of tgs mutants were obtained that had adenylate cyclase activities at least as high as those normally observed in tgs+ strains of E. coli but that exhibited the loss of preference for glucose characteristic of tgs strains.
(a) One type carried a gene, designated cyaS, co-transducible with the structural genes for adenylate cyclase, cya, and for the utilization of F-glucosides, bgl, at min 83 on the E. coli linkage map. Strain PW 193 (ptsPtgscyabgP) has negligible adenylate cyclase activity and, in consequence of both the cya and tgs mutations, does not grow on fumarate unless cyclic AMP is also supplied. When infected with phage P1 that had been propagated on bglcyaS-donor strains, all the transductants selected on fumarate were Bgl-and had high adenylate cyclase activity, but were shown still to carry the tgs marker. They were resistant to 5-thio-~-glucose, and utilized glucose and fructose simultaneously and to the same extent.
(b) The second type of mutant carried a gene, designated cyaM, located at rnin 25 on the E. coli linkage map, co-transducible with purB but less close to ptsG than is the Ptsff marker. Like cyaS mutants, cyaM strains grow on fumarate even though they either lack Enzyme I activity or carry the tgs marker; they are high in adenylate cyclase activity. These strains also utilize glucose and fructose equally. Whereas the cyaS mutation was not found to produce any phenotypic effect in an otherwise wild-type strain, the cyaM mutation increased the adenylate cyclase activity of otherwise isogenic cyaM+ strains approx. 4-fold.
It has been established (Jones-Mortimer et al., 1977; Kornberg & Watts, 1978) that the tgs mutation affects a component of glucose uptake that interacts specifically with the PtsG enzyme system. It appears that, in cyaS+ strains, this component plays a role in ensuring that adenylate cyclase is active. If, as Peterkofsky (1977) suggested, this is brought about by the transfer of phosphate from phosphoenolpyruvate to the membrane-bound adenylate cyclase, the component common both to this process and to glucose uptake may well be the glucose-specific factor 111 described by Kundig (1974) . As a working hypothesis, we postulate that the function of this component might be as illustrated in Fig. 1 , in which its ability to transfer the phosphoryl group to either adenylate cyclase or glucose can be separately modified. Phosphorylation of adenylate cyclase would imply also the existence of a phosphatase activity (designated acp in Fig. 1 ) that returns adenylate cyclase to the inactive state; loss of this enzyme would be expected to increase the activity of adenylate cyclase irrespective of its state of activation by the phosphotransferase system, which is the observed phenotype of the cyaM mutants. Although
